Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Veracyte (Nasdaq: VCYT) has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. CEO Marc Stapley and CFO Rebecca Chambers will engage in a fireside chat on Thursday, September 5, at 2:35 p.m. Eastern Time.
Investors and interested parties can access a live audio webcast of the presentation through Veracyte's website at http://investor.veracyte.com/events-presentations. For those unable to attend the live event, a replay of the webcast will be available for 90 days following the presentation.
This participation highlights Veracyte's commitment to engaging with the investment community and sharing insights about the company's progress and future prospects in the healthcare sector.
Veracyte (Nasdaq: VCYT) ha annunciato la sua partecipazione al 22° Conferenza Annuale Mondiale sulla Salute di Morgan Stanley. L'amministratore delegato Marc Stapley e il direttore finanziario Rebecca Chambers parteciperanno a una chiacchierata informale giovedì 5 settembre, alle 14:35 ora orientale.
Investitori e parti interessate possono accedere a un webcast audio in diretta della presentazione attraverso il sito web di Veracyte all'indirizzo http://investor.veracyte.com/events-presentations. Per coloro che non possono partecipare all'evento dal vivo, un ripasso del webcast sarà disponibile per 90 giorni dopo la presentazione.
Questa partecipazione sottolinea l'impegno di Veracyte nel coinvolgere la comunità degli investitori e nel condividere informazioni sui progressi e sulle prospettive future dell'azienda nel settore sanitario.
Veracyte (Nasdaq: VCYT) ha anunciado su participación en la 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley. El CEO Marc Stapley y la CFO Rebecca Chambers participarán en una charla informal el jueves 5 de septiembre, a las 2:35 p.m. hora del Este.
Los inversores y partes interesadas pueden acceder a un webcast de audio en vivo de la presentación a través del sitio web de Veracyte en http://investor.veracyte.com/events-presentations. Para aquellos que no puedan asistir al evento en vivo, una repetición del webcast estará disponible durante 90 días después de la presentación.
Esta participación destaca el compromiso de Veracyte con la comunidad inversora y la compartición de información sobre el progreso y las perspectivas futuras de la empresa en el sector de la salud.
Veracyte(나스닥: VCYT)는 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. CEO 마크 스테이플리는 CFO 레베카 챔버스와 함께 9월 5일 목요일, 동부 표준시 기준 오후 2시 35분에 대화에 참여할 예정입니다.
투자자와 관계자들은 Veracyte 웹사이트(http://investor.veracyte.com/events-presentations)를 통해 실시간 오디오 웹캐스트에 접근할 수 있습니다. 라이브 이벤트에 참석할 수 없는 경우, 프레젠테이션 후 90일 동안 웹캐스트의 재생이 가능합니다.
이번 참여는 Veracyte가 투자 커뮤니티와 소통하고 회사의 발전 및 의료 분야의 미래 전망에 대한 통찰을 공유하겠다는 의지를 강조합니다.
Veracyte (Nasdaq: VCYT) a annoncé sa participation à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. Le PDG Marc Stapley et la CFO Rebecca Chambers participeront à une discussion informelle le jeudi 5 septembre, à 14h35 heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire audio en direct de la présentation sur le site web de Veracyte à l'adresse http://investor.veracyte.com/events-presentations. Pour ceux qui ne peuvent pas assister à l'événement en direct, une rediffusion du webinaire sera disponible pendant 90 jours après la présentation.
Cette participation met en évidence l'engagement de Veracyte à interagir avec la communauté des investisseurs et à partager des idées sur les progrès et les perspectives futures de l'entreprise dans le secteur de la santé.
Veracyte (Nasdaq: VCYT) hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley angekündigt. CEO Marc Stapley und CFO Rebecca Chambers werden am Donnerstag, den 5. September, um 14:35 Uhr Eastern Time, an einem informellen Gespräch teilnehmen.
Investoren und Interessierte können über die Website von Veracyte unter http://investor.veracyte.com/events-presentations auf ein live Audio-Webcast der Präsentation zugreifen. Für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, steht eine Wiederholung des Webcasts 90 Tage lang nach der Präsentation zur Verfügung.
Diese Teilnahme unterstreicht Veracytes Engagement, mit der Investoren-Community in Kontakt zu treten und Einblicke in den Fortschritt und die Zukunftsaussichten des Unternehmens im Gesundheitssektor zu teilen.
- None.
- None.
A live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. A replay of the webcast will be available for 90 days after the live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).
View source version on businesswire.com: https://www.businesswire.com/news/home/20240826654668/en/
Investors:
Shayla Gorman
investors@veracyte.com
(619) 393-1545
Media:
Tracy Morris
media@veracyte.com
(650) 380-4413
Source: Veracyte, Inc.
FAQ
When is Veracyte (VCYT) presenting at the Morgan Stanley Healthcare Conference?
Who will be representing Veracyte (VCYT) at the Morgan Stanley Healthcare Conference?
How can I watch Veracyte's (VCYT) presentation at the Morgan Stanley Healthcare Conference?
How long will the replay of Veracyte's (VCYT) Morgan Stanley Healthcare Conference presentation be available?
